C13orf18 and C1Orf166 (MULAN) DNA genes methylation are not associated with cervical cancer and precancerous lesions of human papillomavirus genotypes in Iranian women

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 16, 2014, Pages 6745-6748

  Sohrabi, Amir ^a   Mirab Samiee, Siamak ^b   Rahnamaye Farzami, Marjan ^b   Rafizadeh, Mitra ^c   Akhavan, Setareh ^d   Hashemi Bahremani, Mohammad ^c   Modarresl, Mohammad Hossein ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c Research Center of Health Reference Laboratory Ministry of Health and Medical Education ^*  (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C13orf18; C1orf166; Cervical neoplasia; HPV; Iran; methylation

Indexed keywords

KIAA0226L PROTEIN, HUMAN; MITOCHONDRIA-ANCHORED PROTEIN LIGASE, HUMAN; PARAFFIN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

DNA METHYLATION; FEMALE; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IRAN; PAPILLOMAVIRUS INFECTION; PRECANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VIROLOGY;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IRAN; PAPILLOMAVIRUS INFECTIONS; PARAFFIN EMBEDDING; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 84906824056     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.16.6745     Document Type: Article

References (31)

1. Al-Shabanah OA, Hafez MM, Hassan ZK, et al (2014). Methylation of SFRPs and APC Genes in ovarian cancer infected with high risk human papillomavirus. Asian Pac J Cancer Prev,15, 2719-25.
2. Banzai C, Nishino K, Quan J, et al (2013). Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma. Int J Clin Oncol, 19, 127-32.
3. Clifford GM, Rana RK, Franceschi S, et al (2005). Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev, 14, 1157-64.
4. Dueñas-González A, Lizano M, Candelaria M, et al (2005). Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer, 25, 4, 38.
5. Eijsink JJH, Lendvai A, Deregowski V, et al (2012). Four-gene methylation marker panel as triage test in highrisk human papillomavirus positive patients. Int J Cancer, 130, 1861-9.
6. Eijsink JJ, Yang N, Lendvai A, et al (2011). Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study. Gynecol Oncol, 120, 280-3.
7. Hamzi Abdul Raub S, Isa NM, Zailani HA, et al (2013). Distribution of HPV genotypes in cervical cancer in multi-ethnic Malaysia. Asian Pac J Cancer Prev, 15, 651-6.
8. Huisman C, Wisman GB, Kazemier HG, et al (2013). Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by artificial transcription factors. Mol Oncol,7, 669-79.
9. Hwang SJ, Shroyer KR (2012). Biomarkers of cervical dysplasia and carcinoma. J Oncol, 507286, doi: 10.1155/2012/507286.
10. Kasamatsu E, Cubilla AL, Alemany L, et al (2012). Type-specific human papillomavirus distribution in invasive cervical carcinomas in paraguay, a study of 432 cases. J Med Virol, 84, 1628-35.
11. Lan VTT, Thuan TB, Thu DM, et al (2013). Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer. Asian Pac J Cancer Prev, 14, 7713-8.
12. Laudadido J (2013). Human papillomavirus detection: testing methodologies and their clinical utility in cervical cancer screening. Adv Anat Pathol, 20, 158-67.
13. Lee JH, Lee NW, Hong SW, et al (2011). Establishment of an efficient multiplex real-time PCR assay for human papillomavirus genotyping in cervical cytology specimens: comparison with hybrid capture II. Cytopathology, 22, 261-8.
14. Li W, Bengtson MH, Ulbrich A, et al (2008). Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS One, 3, 1487.
15. Limpaiboon T (2012). Epigenetic aberrations in cholangiocarcinoma: potential biomarkers and promising target for novel therapeutic strategies. Asian Pacific J Cancer Prev, 13, 41-5.
16. Ma JQ, Kurban S, Zhao JD, et al (2014). Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from uighur women. Asian Pac J Cancer Prev, 15, 2485-9.
17. Manjari M, Sweta S (2012). Detection of HPV by PCR-a novel step in the prevention of cancer cervix. J Obstet Gynaecol India, 62, 188-91.
18. Mohiuddin MK, Chava S, Upendrum P, et al (2013). Role of human papilloma virus infection and altered methylation of specific genes in esophageal cancer. Asian Pac J Cancer Prev, 14, 4187-93.
19. Nogueira da Costa A, Herceg Z (2012). Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application. Mol Oncol, 6, 704-15.
20. Nunobiki O, Ueda M, Toji E, et al (2011). Genetic polymorphism of cancer susceptibility genes and HPV infection in cervical carcinogenesis. Patholog Res Int, 364069, doi: 10.4061/2011/364069.
21. Othman N, Othman NH (2014). Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation. Asian Pac J Cancer Prev, 15, 2245-9.
22. Snellenberg S, De Strooper LM, Hesselink AT, et al (2012). Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape. BMC Cancer, 23, 12:551.
23. Shayanfar N, Hosseini N, Panahi M, et al (2013). Detection of mucosal type human papillomavirus in cutaneous squamous cell carcinoma in Iran. Pathol Res Pract, 209, 90-4.
24. Sun LL, Cao DY, Yang JX, et al (2012). Population-based case- control study on DAPK1, RAR-2 and MGMT methylation in liquid-based cytology. Arch Gynecol Obstet, 285, 1433-9.
25. Szalmás A, Kónya J (2009). Epigenetic alterations in cervical carcinogenesis. Semin Cancer Biol, 19, 144-52.
26. Turki R, Sait K, Anfinan N, et al (2013). Prevalence of human papillomavirus in women from Saudi Arabia. Asian Pac J Cancer Prev, 14, 3177-81.
27. Yang N, Eijsink JJH, Lendvai A, et al (2009). Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings. Cancer Epidemiol Biomarkers Prev, 18, 3000-7.
28. Wang YY, Li L, Wei S, et al (2013). Human papillomavirus (HPV) infection in women participating in cervical cancer screening from 2006 to 2010 in Shenzhen city, south China. Asian Pac J Cancer Prev, 14, 7483-7.
29. Wang ZM (2014). PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions. Asian Pac J Cancer Prev, 15, 891-4.
30. Wentzensen N, Sherman ME, Schiffman M, et al (2009). Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science. Gynecol Oncol, 112, 293-9.
31. WHO/ICO HPV Information Centre (2010). Human papillomavirus and related cancers, specific Iran summary report. Available at http://www.who.int/hpvcentre.